DBV Technologies

DBV

FR0010417345

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:02 2024-05-14 am EDT			5-day change	1st Jan Change
1.214 ^EUR	+0.66%		-0.65%	-34.34%

May. 14	European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	MT
May. 10	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	MT

DBV Technologies Announces Leaving of Kevin Trapp as Chief Commercial Officer, Effective October 2, 2020

September 09, 2020 at 01:30 am EDT

DBV Technologies announced that Kevin Trapp, Chief Commercial Officer, will be leaving the Company as of October 2, 2020.

Latest news about DBV Technologies

European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	May. 14	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	May. 10	MT
China confirms its awakening	May. 09
Mickey Mouse on Wall Street	May. 08
DBV Technologies: net loss widens in Q1	May. 08	CF
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	Apr. 23	MT
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	Apr. 22	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	Apr. 19	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 17	MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	Apr. 12	MT
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	Apr. 11	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 10	MT
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading	Apr. 08	MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	Apr. 05	MT
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher	Apr. 01	MT
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	Mar. 28	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	Mar. 26	MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading	Mar. 25	MT
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday Trading	Mar. 22	MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday	Mar. 20	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading	Mar. 12	MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading	Mar. 11	MT
DBV Technologies: down sharply, cash flow not reassuring	Mar. 08	CF
DBV Technologies S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Transcript : DBV Technologies S.A., 2023 Earnings Call, Mar 07, 2024	Mar. 07

DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.

Sector

Pharmaceuticals

Calendar

2024-05-16 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for DBV Technologies

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.214 EUR

Average target price

4.733 EUR

Spread / Average Target

+289.90%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
DBV TECHNOLOGIES	-34.34%	125M
MERCK KGAA	+9.85%	72.5B
KYOWA KIRIN CO. LTD.	+12.38%	9.11B
SK BIOPHARMACEUTICALS CO., LTD.	-12.85%	5.07B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+60.16%	5.01B
YUHAN CORPORATION	+1.60%	3.85B
BETTA PHARMACEUTICALS CO., LTD.	-19.20%	2.46B
INDIVIOR PLC	+18.65%	2.44B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+24.62%	2.27B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-27.46%	2.26B

Specialty & Advanced Pharmaceuticals